Many deaths from breast cancer are preventable, with 28% of the years of healthy life lost to the disease attributable to six modifiable risk factors, according to a new study published in The Lancet ...

Two men are in police custody in Prince George County after they were caught with marijuana, narcotics and a large amount of ...

Io Therapeutics, Inc. in Spring, Texas, announces collaborative publication of data from preclinical studies with scientists at The University of Texas MD Anderson Cancer Center demonstrating ...

Roche Holdings AG on Monday shared results from the phase 3 persevERA Breast Cancer study of giredestrant combined with palbociclib in advanced cancer patients. Trial Misses Primary Goal The trial ...

Stormont’s health minister has yet to say whether Northern Ireland will follow an NHS England plan to stop the prescription of opposite-sex hormones to teenagers amid safety concerns.

“Knitting takes you through a process of healing. Once you are not thinking about your disease, you are positive and that positive mind helps you, because healing starts from your mind,” she said.

Scientists at Oregon Health & Science University have developed a new molecule that could open the door to treating triple-negative breast cancer, one of the most aggressive and difficult-to-treat ...

Having periods is normal, but talking about it with your kid might not be. Here's how to do it right, according to doctors.

Priority review and Project Orbis evaluation advance potential post-neoadjuvant use of trastuzumab deruxtecan for high-risk HER2-positive early breast cancer with residual disease after neoadjuvant ...

Olema Pharmaceuticals (OLMA) stock plummeted 41% after Roche's Phase 3 breast cancer trial failed its primary endpoint, ...

persevERA is the first of two distinct Phase III studies in the first-line setting; the pionERA study of giredestrant in combination with physician’s choice of cyclin-dependent kinase (CDK)4/6 ...

Scientists have developed an AI system that analyzes complex gene-expression signatures to estimate the likelihood that a tumor will spread.